US Patent
US11260064 — Stable corticosteroid compositions
Formulation · Assigned to Viropharma Biologics LLC · Expires 2039-01-10 · 13y remaining
Vulnerability score
55/100
Moderate — design-around opportunities exist
What this patent protects
This patent protects pharmaceutical compositions that combine a corticosteroid with an antioxidant for treating or preventing gastrointestinal tract inflammation.
USPTO Abstract
The invention relates to pharmaceutical compositions comprising a corticosteroid and an antioxidant. The invention further relates to methods of treating, preventing, or alleviating the symptoms of and inflammation associated with inflammatory diseases and conditions of the gastrointestinal tract comprising administering the pharmaceutical compositions comprising a corticosteroid and an antioxidant.
Drugs covered by this patent
- Pulmicort Respules (BUDESONIDE) · AstraZeneca K.K.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.